BioStem Technologies (BSEM) Earnings Date, Estimates & Call Transcripts $14.44 -0.98 (-6.36%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Earnings Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest BioStem Technologies Latest Earnings SummaryLatest Earnings DateNov. 12EstimatedActual EPS (Nov. 12) $0.32 Beat By $0.01 Consensus EPS (Nov. 12) $0.31 BioStem Technologies posted Q3 2024 earnings on November 12, 2024, reporting an EPS of $0.32, which topped the consensus estimate of $0.31 by $0.01. Quarterly revenue was reported to be $82.56 million, above the consensus estimate of $78.22 million. With a trailing EPS of $0.68 and a P/E Ratio of 21.24, BioStem Technologies' earnings are expected to grow 62.41% next year, from $1.41 to $2.29 per share. Conference CallConference Call TranscriptPowered by Get BioStem Technologies Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioStem Technologies and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBSEM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BSEM Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. BioStem Technologies Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241$0.74$0.74$0.74Q2 20241$0.77$0.77$0.77Q3 20241$0.36$0.36$0.36Q4 20241$0.37$0.37$0.37FY 20244$2.24$2.24$2.24Q1 20251$0.79$0.79$0.79Q2 20251$0.80$0.80$0.80Q3 20251$0.80$0.80$0.80Q4 20251$0.81$0.81$0.81FY 20254$3.20$3.20$3.20Q1 20261$0.52$0.52$0.52Q2 20261$0.57$0.57$0.57Q3 20261$0.61$0.61$0.61 BioStem Technologies Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/12/2024-$0.31$0.32+$0.01$0.32$78.22M$82.56M8/12/2024Q2 2024$0.12$0.30+$0.18$0.30$43.99M$74.49M5/14/2024Q1 2024$0.74$0.20 -$0.54$0.20$12.70M$41.90M4/1/2024Q4 2023--$0.14 -$0.14-$0.14$11.40M$11.44M11/13/2023Q3 2023-$0.18$0.03+$0.21$0.03$1.39M$3.60M BioStem Technologies Earnings - Frequently Asked Questions When did BioStem Technologies announce their last quarterly earnings? BioStem Technologies (OTCMKTS:BSEM) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on BSEM's earnings history. Did BioStem Technologies beat their earnings estimates last quarter? In the previous quarter, BioStem Technologies (OTCMKTS:BSEM) reported $0.32 earnings per share (EPS) to beat the analysts' consensus estimate of $0.31 by $0.01. Learn more on analysts' earnings estimate vs. BSEM's actual earnings. How can I listen to BioStem Technologies's earnings conference call? The conference call for BioStem Technologies's latest earnings report can be listened to online. Listen to Conference Call How can I read BioStem Technologies's conference call transcript? The conference call transcript for BioStem Technologies's latest earnings report can be read online. Read Transcript How much revenue does BioStem Technologies generate each year? BioStem Technologies (OTCMKTS:BSEM) has a recorded annual revenue of $16.68 million. What is BioStem Technologies's price-to-earnings ratio? BioStem Technologies (OTCMKTS:BSEM) has a trailing price-to-earnings ratio of 21.24 and a forward price-to-earnings ratio of 10.24. What is BioStem Technologies's EPS forecast for next year? BioStem Technologies's earnings are expected to grow from $1.41 per share to $2.29 per share in the next year, which is a 62.41% increase. More Earnings Resources from MarketBeat Related Companies Rocket Pharmaceuticals Earnings Results OPKO Health Earnings Results Bicycle Therapeutics Earnings Results Avadel Pharmaceuticals Earnings Results Owens & Minor Earnings Results Vir Biotechnology Earnings Results Brookdale Senior Living Earnings Results CeriBell Earnings Results Curaleaf Earnings Results The Pennant Group Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings This is the worst sign for the U.S. stock market in 50 years (Ad)The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone" Click here to see Dan's new, urgent warning about the U.S. market for 2025. This page (OTCMKTS:BSEM) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioStem Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioStem Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BSEM Stock Alerts